J. Ferlay, H. Shin, F. Bray, D. Forman, C. Mathers et al., Estimates of worldwide burden of cancer in 2008: GLOBOCAN, Int J Cancer, vol.127, pp.2893-917, 2008.

J. Bernier, C. Domenge, M. Ozsahin, K. Matuszewska, J. Lefèbvre et al., Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer, N Engl J Med, vol.350, pp.1945-52, 2004.

J. S. Cooper, T. F. Pajak, A. A. Forastiere, J. Jacobs, B. H. Campbell et al., Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck, N Engl J Med, vol.350, pp.1937-1981, 2004.

K. K. Ang, J. Harris, R. Wheeler, R. Weber, D. I. Rosenthal et al., Human papillomavirus and survival of patients with oropharyngeal cancer, N Engl J Med, vol.363, pp.24-35, 2010.

M. Nordsmark, S. M. Bentzen, V. Rudat, D. Brizel, E. Lartigau et al., Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study, Radiother Oncol, vol.77, pp.18-24, 2005.

K. Selvendiran, A. Bratasz, M. L. Kuppusamy, M. F. Tazi, B. K. Rivera et al., Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3, Int J Cancer, vol.125, pp.2198-204, 2009.

D. M. Brizel, G. S. Sibley, L. R. Prosnitz, R. L. Scher, and M. W. Dewhirst, Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck, Int J Radiat Oncol Biol Phys, vol.38, pp.285-294, 1997.

F. Clatot, J. Picquenot, O. Choussy, S. Gouérant, C. Moldovan et al., Intratumoural level of SDF-1 correlates with survival in head and neck squamous cell carcinoma, Oral Oncol, vol.47, pp.1062-1070, 2011.

H. Kajiyama, K. Shibata, M. Terauchi, K. Ino, A. Nawa et al., Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma, Int J Cancer, vol.122, pp.91-100, 2008.

Y. Sun, J. Wang, C. E. Shelburne, D. E. Lopatin, A. M. Chinnaiyan et al., Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo, J Cell Biochem, vol.89, pp.462-73, 2003.

M. K. Wendt, P. A. Johanesen, N. Kang-decker, D. G. Binion, V. Shah et al., Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis, Oncogene, vol.25, pp.4986-97, 2006.

A. Müller, B. Homey, H. Soto, N. Ge, D. Catron et al., Involvement of chemokine receptors in breast cancer metastasis, Nature, vol.410, pp.50-56, 2001.

M. Cojoc, C. Peitzsch, F. Trautmann, L. Polishchuk, G. D. Telegeev et al., Emerging targets in cancer management: role of the CXCL12/CXCR4 axis, OncoTargets Ther, vol.6, pp.1347-61, 2013.

A. O. Rehman and C. Wang, SDF-1alpha promotes invasion of head and neck squamous cell carcinoma by activating NF-kappaB, J Biol Chem, vol.283, pp.19888-94, 2008.

D. Uchida, T. Onoue, N. Kuribayashi, Y. Tomizuka, T. Tamatani et al., Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases, Eur J Cancer, vol.2011, issue.47, pp.452-461, 1990.

F. Jin, U. Brockmeier, F. Otterbach, and E. Metzen, New insight into the SDF-1/CXCR4 axis in a breast carcinoma model: hypoxia-induced endothelial SDF-1 and tumor cell CXCR4 are required for tumor cell intravasation, Mol Cancer Res, vol.10, pp.1021-1052, 2012.

S. E. Rademakers, J. Lok, A. J. Van-der-kogel, J. Bussink, and J. Kaanders, Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1a, CAIX, LDH-5, GLUT-1, MCT1 and MCT4, BMC Cancer, vol.11, p.167, 2011.

D. M. Brizel, T. Schroeder, R. L. Scher, S. Walenta, R. W. Clough et al., Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer, Int J Radiat Oncol Biol Phys, vol.51, pp.349-53, 2001.

D. Virós, M. Camacho, I. Zarraonandia, J. García, M. Quer et al., Prognostic role of MMP-9 expression in head and neck carcinoma patients treated with radiotherapy or chemoradiotherapy, Oral Oncol, vol.49, pp.322-327, 2013.

A. Ansell, F. Jerhammar, R. Ceder, R. Grafström, R. Grénman et al., Matrix metalloproteinase-7 and -13 expression associate to cisplatin resistance in head and neck cancer cell lines, Oral Oncol, vol.45, pp.866-71, 2009.

B. Hundsdorfer, H. Zeilhofer, K. P. Bock, P. Dettmar, M. Schmitt et al., Tumour-associated urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in normal and neoplastic tissues of patients with squamous cell cancer of the oral cavity -clinical relevance and prognostic value, J Cranio-Maxillo-Facial Surg, vol.33, pp.191-197, 2005.

L. Speleman, J. Kerrebijn, M. P. Look, C. A. Meeuwis, J. A. Foekens et al., Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma, Head Neck, vol.29, pp.341-50, 2007.

J. Han, S. H. Oh, F. Morgillo, J. N. Myers, E. Kim et al., Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer, J Natl Cancer Inst, vol.97, pp.1272-86, 2005.

L. H. Sobin, M. K. Gospodarowicz, and C. Wittekind, International union against Cancer. TNM classification of malignant tumours, 2010.

G. Wright, B. Tan, A. Rosenwald, E. H. Hurt, A. Wiestner et al., A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma, Proc Natl Acad Sci, vol.100, pp.9991-9997, 2003.

C. Ambroise and G. J. Mclachlan, Selection bias in gene extraction on the basis of microarray gene-expression data, Proc Natl Acad Sci, vol.99, pp.6562-6568, 2002.

D. S. Rickman, R. Millon, D. Reynies, A. Thomas, E. Wasylyk et al., Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays, Oncogene, vol.27, pp.6607-6629, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00350835

M. A. Pavón, M. Parreño, M. Téllez-gabriel, F. J. Sancho, M. López et al., Gene expression signatures and molecular markers associated with clinical outcome in locally advanced head and neck carcinoma, Carcinogenesis, vol.33, pp.1707-1723, 2012.

L. Gossage and T. Eisen, Alterations in VHL as potential biomarkers in renal-cell carcinoma, Nat Rev Clin Oncol, vol.7, pp.277-88, 2010.

R. J. Motzer, T. E. Hutson, P. Tomczak, M. D. Michaelson, R. M. Bukowski et al., Sunitinib versus interferon alfa in metastatic renal-cell carcinoma, N Engl J Med, vol.356, pp.115-139, 2007.

B. Escudier, A. Pluzanska, P. Koralewski, A. Ravaud, S. Bracarda et al., Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial, Lancet, vol.370, pp.2103-2114, 2007.

M. P. Rosin, X. Cheng, C. Poh, W. L. Lam, Y. Huang et al., Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia, Clin Cancer Res, vol.6, pp.357-62, 2000.

T. Asakawa, M. Esumi, S. Endo, A. Kida, and M. Ikeda, Tongue cancer patients have a high frequency of allelic loss at the von Hippel-Lindau gene and other loci on 3p, Cancer, vol.112, pp.527-561, 2008.

H. Amano, I. Hayashi, H. Endo, H. Kitasato, S. Yamashina et al., Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth, J Exp Med, vol.197, pp.221-253, 2003.

H. Katoh, K. Hosono, Y. Ito, T. Suzuki, Y. Ogawa et al., COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems, Am J Pathol, vol.176, pp.1469-83, 2010.

V. Mirisola, A. Zuccarino, B. E. Bachmeier, M. P. Sormani, J. Falter et al., CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival, Eur J Cancer, vol.45, pp.2579-87, 2009.

S. A. Williams, Y. Harata-lee, I. Comerford, R. L. Anderson, M. J. Smyth et al., Multiple functions of CXCL12 in a syngeneic model of breast cancer, Mol Cancer, vol.9, p.250, 2010.

Z. Granot, E. Henke, E. A. Comen, T. A. King, L. Norton et al., Tumor entrained neutrophils inhibit seeding in the premetastatic lung, Cancer Cell, vol.20, pp.300-314, 2011.

A. P. Halestrap, The SLC16 gene family -structure, role and regulation in health and disease, Mol Aspects Med, vol.34, pp.337-386, 2013.

J. M. Curry, M. Tuluc, D. Whitaker-menezes, J. A. Ames, A. Anantharaman et al., Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer, Cell Cycle, vol.12, pp.1371-84, 2013.

A. Wolf, S. Agnihotri, J. Micallef, J. Mukherjee, N. Sabha et al., Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme, J Exp Med, vol.208, pp.313-339, 2011.

G. Thurston, I. Noguera-troise, and G. D. Yancopoulos, The delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth, Nat Rev Cancer, vol.7, pp.327-358, 2007.

M. I. Koukourakis, A. Giatromanolaki, E. Sivridis, K. C. Gatter, and A. L. Harris, High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC), Angiogenesis, vol.16, pp.343-51, 2013.

C. C. Wykoff, N. J. Beasley, P. H. Watson, K. J. Turner, J. Pastorek et al., Hypoxia-inducible expression of tumor-associated carbonic anhydrases, Cancer Res, vol.60, pp.7075-83, 2000.

M. I. Koukourakis, A. Giatromanolaki, E. Sivridis, K. Simopoulos, J. Pastorek et al., Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy, Clin Cancer Res, vol.7, pp.3399-403, 2001.

N. T. Brockton, A. C. Klimowicz, P. Bose, S. K. Petrillo, M. Konno et al., High stromal carbonic anhydrase IX expression is associated with nodal metastasis and decreased survival in patients with surgically-treated oral cavity squamous cell carcinoma, Oral Oncol, vol.48, pp.615-637, 2012.

J. G. Eriksen and J. Overgaard, Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study, Radiother Oncol, vol.83, pp.383-391, 2007.

S. Peridis, G. Pilgrim, I. Athanasopoulos, and K. Parpounas, Carbonic anhydrase-9 expression in head and neck cancer: a meta-analysis, Eur Arch Oto-Rhino-Laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc EUFOS Affil Ger Soc Oto-Rhino-Laryngol -Head Neck Surg, vol.268, pp.661-70, 2011.

J. F. Dipersio, E. A. Stadtmauer, A. Nademanee, I. Micallef, P. J. Stiff et al., Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma, Blood, vol.113, pp.5720-5726, 2009.

G. L. Uy, M. P. Rettig, I. H. Motabi, K. Mcfarland, K. M. Trinkaus et al., A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia, Blood, vol.119, pp.3917-3941, 2012.